YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFNL1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,886
Award facts
- Contract value 100% obligated
- $18,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,886.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on January 19, 2026, with an ultimate completion date of February 9, 2026, carries no set-aside designation, indicating the award was made through open competition. This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense medical facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain since its System for Award Management registration in 2001, demonstrating substantial federal contracting capability across multiple therapeutic categories and product lines. The company's prime vendor contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the issuance of delivery orders for comprehensive pharmaceutical products including branded and generic medications, biologics, vaccines, and medical consumables. This delivery order for YF-VAX represents one of numerous purchase orders issued to the company by the Defense Logistics Agency's Medical Supply Chain division to support recurring medical supply needs of military healthcare facilities globally, with no subcontractors identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FFNL1?
SPE2DR26FFNL1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 19, 2026.
How much is contract SPE2DR26FFNL1 worth?
The government has obligated $18,886 on SPE2DR26FFNL1.
Is contract SPE2DR26FFNL1 an order under another contract?
Yes. SPE2DR26FFNL1 is a delivery order under SPE2DR25D9249, an indefinite delivery contract.
Was contract SPE2DR26FFNL1 competed?
The extent of competition for SPE2DR26FFNL1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award